HIF1A and breast carcinoma: Taken together, cell line modelling and human cancer sample analyses reveal that ALDO+RA treatment results in activation of HIF-1α and the hypoxia response, which promotes glycolysis and acts as a tumour suppressor in breast cancer cells, possibly due to induction of autophagy or ‘self-digestion’ of the tumour cells.